Preoperative technetium Tc 99m sestamibi SPECT imaging in the management of primary hyperparathyroidism in patients with concomitant multinodular goiter

被引:27
|
作者
Lorberboym, M
Ezri, T
Schachter, PP [1 ]
机构
[1] Tel Aviv Univ, Sackler Fac Med, Edith Wolfson Med Ctr, Dept Surg A, IL-58100 Holon, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Edith Wolfson Med Ctr, Dept Nucl Med, IL-58100 Holon, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Edith Wolfson Med Ctr, Dept Anesthesiol, IL-58100 Holon, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Edith Wolfson Med Ctr, Dept Gen Surg, IL-58100 Holon, Israel
关键词
D O I
10.1001/archsurg.140.7.656
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hypothesis: Preoperative parathyroid and thyroid imaging using technetium Tc 99m sestamibi scintigraphy-single-photon emission computed tomography (Tc 99m MIBI SPECT) and technetium Tc 99m sodium. pertechnetate, respectively, in patients with parathyroid adenomas and concomitant multinodular goiters enables the selection of those suitable for minimally invasive radio-guided surgery. Design: One hundred thirty patients with primary hyperparathyroidism were treated surgically during a 30-month period. Forty-one of these 130 patients had an associated multinodular goiter. All patients underwent planar and SPECT parathyroid scintigraphy using Tc 99m MIBI, and thyroid scintigraphy with technetium Tc 99m pertechnetate 2 to 5 days before surgery. On the morning of surgery each patient was reinjected with Tc 99m MIBI for intraoperative localization and validation. Minimally invasive radio-guided parathyroidectomy was performed using a handheld gamma-detection device with a thyroid probe. Removed glands were submitted for histopathologic examination for comparison with the scintigraphic results. Quantitative analysis of parathyroid activity was performed. Results: Minimally invasive, radioguided parathyroidectomy was successfully performed in 21 (51%) of 41 patients who had a concomitant multinodular goiter. The remaining 20 patients underwent standard neck exploratory surgery because of associated thyroid disease; 5 of them had malignant thyroid disease. Among the 41 patients planar scintigraphy correctly identified 28 adenomas (68%). Single-photon emission computed tomographic imaging identified an additional 11 adenomas for a sensitivity of 95% and a specificity of 100%. Moreover, SPECT imaging correctly identified malignant thyroid nodules in 4 of 5 patients. Technetium Tc 99m MIBI retention was noted in only 25 adenomas (61%) while the remaining adenomas demonstrated a rapid washout. The average uptake ratio of parathyroid counts to maximum thyroid activity was significantly correlated with parathyroid hormone levels before surgery (P =.04). Conclusions: Our data encourage the use of preoperative SPECT imaging of parathyroid adenomas in patients who have multinodular goiters to select those suitable for minimally invasive radioguided surgery. This technique also offers important information regarding thyroid nodules that are suspicious for malignancy. The intraoperative gamma-probe technique enables the surgeon to focus his or her search, provides instant feedback regarding the progress of the operation, reduces surgical trauma and complications, and yields better cosmetic results. Patients with higher presurgical parathyroid hormone levels may especially benefit from radioguided surgery.
引用
收藏
页码:656 / 660
页数:5
相关论文
共 50 条
  • [41] Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT
    Chen, CC
    Holder, LE
    Scovill, WA
    Tehan, AM
    Gann, DS
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (06) : 834 - 839
  • [42] Parathyroid localization with high-resolution ultrasound and technetium Tc 99m sestamibi
    Purcell, GP
    Dirbas, FM
    Jeffrey, RB
    Lane, MJ
    Desser, T
    McDougall, R
    Weigel, RJ
    ARCHIVES OF SURGERY, 1999, 134 (08) : 824 - 828
  • [43] Radio-guided parathyroidectomy in patients with primary hyperparathyroidism and concomitant multinodular goiter
    Wolfgang Sendt
    Knut Spieker
    Gertrud Michael
    Karin Jandt
    Annelore Altendorf-Hofmann
    Surgery Today, 2010, 40 : 825 - 830
  • [44] CHOOSING A TL-201 OR TECHNETIUM 99M SESTAMIBI IMAGING PROTOCOL
    UDELSON, JE
    JOURNAL OF NUCLEAR CARDIOLOGY, 1994, 1 (05) : S99 - S108
  • [45] Radio-guided parathyroidectomy in patients with primary hyperparathyroidism and concomitant multinodular goiter
    Sendt, Wolfgang
    Spieker, Knut
    Michael, Gertrud
    Jandt, Karin
    Altendorf-Hofmann, Annelore
    SURGERY TODAY, 2010, 40 (09) : 825 - 830
  • [46] Importance of oxyphil cells for 99m Tc-sestamibi uptake in primary hyperparathyroidism: a retrospective observational study
    Dropmann, Jan Axl
    Kleespies, Axel
    Fuerst, Heinrich
    Kremer, Marcus
    Drefs, Moritz
    Neuberger, Michael
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2025,
  • [47] Preoperative parathyroid gland localization with technetium-99m sestamibi in secondary hyperparathyroidism
    Francesca Pons
    Josep-Vicens Torregrosa
    Sergi Vidal-Sicart
    Lluís Sabater
    David Fuster
    Laureano Fernández-Cruz
    Ramón Herranz
    European Journal of Nuclear Medicine, 1997, 24 : 1494 - 1498
  • [48] Technetium-99m-sestamibi/pertechnetate subtraction scintigraphy vs ultrasonography for preoperative localization in primary hyperparathyroidism
    Berczi, C
    Mezosi, E
    Galuska, L
    Varga, J
    Bajnok, L
    Lukács, G
    Balázs, G
    EUROPEAN RADIOLOGY, 2002, 12 (03) : 605 - 609
  • [49] Technetium-99m-sestamibi/pertechnetate subtraction scintigraphy vs ultrasonography for preoperative localization in primary hyperparathyroidism
    C. Berczi
    E. Mezõsi
    L. Galuska
    J. Varga
    L. Bajnok
    G. Lukács
    G. Balázs
    European Radiology, 2002, 12 : 605 - 609
  • [50] Preoperative parathyroid gland localization with technetium-99m sestamibi in secondary hyperparathyroidism
    Pons, F
    Torregrosa, JV
    Vidal-Sicart, S
    Sabater, L
    Fuster, D
    Fernández-Cruz, L
    Herranz, R
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (12) : 1494 - 1498